- Home
- NSRX vs KPLT Comparison
NSRX vs KPLT Comparison
Compare NSRX & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSRX | KPLT |
|---|---|---|
| Founded | 2019 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 39.2M |
| IPO Year | 2024 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NSRX | KPLT |
|---|---|---|
| Price | $4.10 | $5.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $19.67 | $10.00 |
| AVG Volume (30 Days) | 12.3K | ★ 83.3K |
| Earning Date | 03-25-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 98.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,761,000.00 |
| Revenue This Year | N/A | $18.62 |
| Revenue Next Year | N/A | $15.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.03 |
| 52 Week Low | $1.98 | $5.50 |
| 52 Week High | $9.50 | $24.15 |
Technical Indicators
Market Signals| Indicator | NSRX | KPLT |
|---|---|---|
| Relative Strength Index (RSI) | 64.61 | 38.34 |
| Support Level | $2.90 | N/A |
| Resistance Level | $4.49 | $7.23 |
| Average True Range (ATR) | 0.28 | 0.65 |
| MACD | 0.04 | -0.10 |
| Stochastic Oscillator | 89.52 | 4.16 |
Price Performance
Historical ComparisonAbout NSRX Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.